139 related articles for article (PubMed ID: 6529162)
1. [Comparative double-blind study: alizapride-metoclopramide].
Oberling F
Ann Gastroenterol Hepatol (Paris); 1984; 20(1):59-61. PubMed ID: 6529162
[TBL] [Abstract][Full Text] [Related]
2. [Alizapride in a double-blind trial with metoclopramide in nausea and vomiting caused by radiotherapy].
Budach V; Krüger K
Fortschr Med; 1983 Oct; 101(39):1792-4. PubMed ID: 6642386
[TBL] [Abstract][Full Text] [Related]
3. [Alizapride in upper digestive endoscopy. A double-blind study vs metoclopramide and placebo].
Bongiorno A; Cataldo MG; Salvia A; D'Aiuto A; Ciranni C
Minerva Dietol Gastroenterol; 1989; 35(4):265-8. PubMed ID: 2695861
[TBL] [Abstract][Full Text] [Related]
4. Droperidol, alizapride and metoclopramide in the prevention and treatment of post-operative emetic sequelae.
Kauste A; Tuominen M; Heikkinen H; Gordin A; Korttila K
Eur J Anaesthesiol; 1986 Jan; 3(1):1-9. PubMed ID: 3780685
[TBL] [Abstract][Full Text] [Related]
5. Anti-emetic effect of high-dose metoclopramide vs alizapride--a randomised crossover study.
Seng KT; Tiong CE; Hiang TC
Br J Clin Pharmacol; 1994 Sep; 38(3):282-4. PubMed ID: 7826833
[TBL] [Abstract][Full Text] [Related]
6. [Control of the emesis induced by cisplatin in patients with head and neck neoplasms. Randomized study of metoclopramide alizapride and placebo].
Denaro A; Rossi M; Garozzo A; Matera M; Neri V
G Ital Oncol; 1990; 10(1-2):29-34. PubMed ID: 2192985
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of a new antiemetic, alizapride, in cancerology (author's transl)].
Cupissol D; Favier F; Favier C; Serrou B
Sem Hop; 1982 Jun; 58(22):1370-3. PubMed ID: 6287597
[TBL] [Abstract][Full Text] [Related]
8. [A double-blind study of alizapride in nausea and emesis induced by cancer chemotherapeutic agents (author's transl)].
Viala JJ; Girard D; Cordier JF
Sem Hop; 1982 Feb; 58(6):371-4. PubMed ID: 6280306
[No Abstract] [Full Text] [Related]
9. [Alizapride vs metoclopramide in the control of emesis induced by chemotherapy].
Gioffrè Florio MA; Pollicino A; Saitta FP; Manganaro T; Venuti A
G Ital Oncol; 1987; 7(4):205-7. PubMed ID: 3505914
[No Abstract] [Full Text] [Related]
10. [Study of cipropride in the treatment of digestive disorders induced by anticancer chemotherapy. Double-blind study using metoclopramide].
Cristau P; Laverdant C; Coquelin JP; Narbonne G
Med Chir Dig; 1981; 10(4):359-64. PubMed ID: 7029166
[No Abstract] [Full Text] [Related]
11. [Treatment of vomiting in infants and children induced by acute infectious pathology. A comparative study of alizapride versus metopimazine].
Debray H; Guihard J; Peyramond D; Tron P
Ann Pediatr (Paris); 1990 Dec; 37(10):683-7. PubMed ID: 2291597
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy.
Basurto C; Roila F; Del Favero A; Ballatori E; Minotti V; Tonato M
Cancer Invest; 1988; 6(5):475-9. PubMed ID: 3063335
[TBL] [Abstract][Full Text] [Related]
13. [Antiemetic and antinauseant effect of alizapride in patients subjected to antiblastic infusion chemotherapy in a day-hospital regime].
Cicchetti F; Viganò P; Borghi CM; Franzini A; Alfano G; Antolini C
G Ital Oncol; 1989; 9(1):18-21. PubMed ID: 2707835
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis.
Saller R; Hellenbrecht D
Cancer Treat Rep; 1985 Nov; 69(11):1301-3. PubMed ID: 3912040
[TBL] [Abstract][Full Text] [Related]
15. Alizapride, a new substituted benzamide, as an antiemetic during cancer chemotherapy.
Joss RA; Galeazzi RL; Bischoff AK; Brunner KW
Eur J Clin Pharmacol; 1985; 27(6):721-5. PubMed ID: 3987777
[TBL] [Abstract][Full Text] [Related]
16. Alizapride in the prevention of postoperative vomiting. A double-blind comparison.
Vanacker B; Van Aken H
Acta Anaesthesiol Belg; 1988; 39(4):247-50. PubMed ID: 3232497
[TBL] [Abstract][Full Text] [Related]
17. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
[TBL] [Abstract][Full Text] [Related]
18. [Antiblastic agent-induced vomiting: possibilities of its prevention and alizapride therapy].
Petrella V; Cantone PA; Alciato P; Gagliardini R; Fico D
Minerva Med; 1989 Apr; 80(4):389-92. PubMed ID: 2725942
[TBL] [Abstract][Full Text] [Related]
19. [Alizapride in the treatment of vomiting induced by cytostatic agents].
Bierbaum HG
Fortschr Med; 1983 Apr; 101(14):662-4. PubMed ID: 6852737
[TBL] [Abstract][Full Text] [Related]
20. Fractionated chemotherapy--granisetron or conventional antiemetics? The Granisetron Study Group.
Diehl V
Eur J Cancer; 1992; 28A Suppl 1():S21-8. PubMed ID: 1320916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
